We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,160
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSNC icon
7626
PUT
SS&C Technologies
SSNC
$18.1B
$213K ﹤0.01%
+4,100
New +$208K
UBS icon
7627
CALL
UBS Group
UBS
$173B
$213K ﹤0.01%
13,900
-17,700
-56% -$288K
AKCA
7628
DELISTED
Akcea Therapeutics Inc
AKCA
$213K ﹤0.01%
+8,983
New +$214K
DNL icon
7629
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$481M
$212K ﹤0.01%
7,446
-72,032
-91% -$2.12M
EBS icon
7630
CALL
Emergent Biosolutions
EBS
$373M
$212K ﹤0.01%
4,200
-1,300
-24% -$67.7K
FOR icon
7631
PUT
Forestar Group
FOR
$1.44B
$212K ﹤0.01%
10,200
-8,300
-45% -$186K
HCM icon
7632
HUTCHMED
HCM
$1.93B
$212K ﹤0.01%
7,029
-2,645
-27% -$84K
LEGR icon
7633
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$131M
$212K ﹤0.01%
7,357
-78,209
-91% -$2.3M
SABR icon
7634
CALL
Sabre
SABR
$731M
$212K ﹤0.01%
+8,600
New +$199K
SIMO icon
7635
PUT
Silicon Motion
SIMO
$8.6B
$212K ﹤0.01%
4,000
-11,900
-75% -$584K
DPLO
7636
CALL
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$212K ﹤0.01%
8,300
-2,400
-22% -$56K
YAO
7637
CALL
DELISTED
Invesco China All-Cap ETF
YAO
$212K ﹤0.01%
6,200
-4,600
-43% -$166K
SKF icon
7638
ProShares UltraShort Financials
SKF
$10.3M
$211K ﹤0.01%
634
-97
-13% -$31.6K
TPH
7639
CALL
DELISTED
Tri Pointe Homes
TPH
$211K ﹤0.01%
+12,900
New +$220K
DSKE
7640
PUT
DELISTED
Daseke, Inc. Common Stock
DSKE
$211K ﹤0.01%
+21,200
New +$197K
SPA
7641
PUT
DELISTED
Sparton
SPA
$211K ﹤0.01%
+11,100
New +$205K
AMSC icon
7642
American Superconductor
AMSC
$1.42B
$210K ﹤0.01%
+29,934
New +$196K
DLB icon
7643
PUT
Dolby
DLB
$5.51B
$210K ﹤0.01%
+3,400
New +$216K
EWX icon
7644
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$652M
$210K ﹤0.01%
+4,422
New +$224K
POR icon
7645
CALL
Portland General Electric
POR
$5.8B
$210K ﹤0.01%
+4,900
New +$202K
DBGR
7646
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
$210K ﹤0.01%
7,875
-10,381
-57% -$290K
XOG
7647
CALL
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$210K ﹤0.01%
+14,300
New +$207K
ENLK
7648
PUT
DELISTED
EnLink Midstream Partners, LP
ENLK
$210K ﹤0.01%
13,500
+2,600
+24% +$40.2K
ATRA icon
7649
Atara Biotherapeutics
ATRA
$75.5M
$209K ﹤0.01%
227
-592
-72% -$636K
ELME
7650
CALL
Elme Communities
ELME
$143M
$209K ﹤0.01%
6,900
-2,500
-27% -$71.5K

Similar funds

Citadel Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.